← Leaderboards
Hugh Jeffrey Lawrence
Northern California Institute Res &Educ
$1,325,734
Attributed
$1,325,734
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,325,734 · 2
By mechanism
R01$1,027,734 · 1
R21$298,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Northern California Institute Res &Educ
Same institution · by research overlap
- Corey Largman$3,036,902
- Rajvir Dahiya$21,076,281
- Rajabrata Sarkar$5,432,111
- Kenneth R Feingold$4,714,504
- Frank M Longo$8,079,856
Others in their field
Top investigators on “Cell Differentiation”
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- John M Lachin · George Washington University$118,672,444
- David M Nathan · Massachusetts Institute Of Technology$118,672,444
- David Heimbrook · Leidos Biomedical Research, Inc.$116,528,280
- Israel David Goldman · Yeshiva University$52,846,708
Research focus
Cell DifferentiationLaboratory MouseHomeobox GenesTranscription FactorGene ExpressionGene TargetingGenetic RegulationGenetic TranscriptionHematopoiesisHematopoietic Stem CellsMicroarray TechnologyProtein Structure FunctionRetinoidsTissue /Cell CultureDna Binding ProteinCell ProliferationOligonucleotidesDouble Stranded RnaDrug ResistanceApoptosisGene Induction /RepressionAntisense Nucleic AcidAcute Myelogenous LeukemiaMyeloid Stem Cell
Grant awards (6)
THE ROLE OF HOX HOMEOBOX GENES IN NORMAL HEMATOPOIESIS$268,436
R01 · FY2003 · DK
THE ROLE OF HOX HOMEOBOX GENES IN NORMAL HEMATOPOIESIS$260,617
R01 · FY2002 · DK
HOXA9 GENE AS A THERAPEUTIC TARGET IN LEUKEMIA$149,000
R21 · FY2002 · CA
THE ROLE OF HOX HOMEOBOX GENES IN NORMAL HEMATOPOIESIS$253,026
R01 · FY2001 · DK
HOXA9 GENE AS A THERAPEUTIC TARGET IN LEUKEMIA$149,000
R21 · FY2001 · CA
THE ROLE OF HOX HOMEOBOX GENES IN NORMAL HEMATOPOIESIS$245,655
R01 · FY2000 · DK